Romiplostim for Oral TPO-RA Resistant ITP | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Romiplostim for Oral TPO-RA Resistant ITP	Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, autoimmune disease, blood coagulation disease, blood platelet disease, hematologic disorder, hemorrhagic disease, immune system disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathy	Recruiting	Not applicable	2026-05-28		NCT07612319

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Affiliated Hospital of Nantong University	71
Changshu Affiliated Hospital of Soochow University	2
Shanghai Tong Ren Hospital	14
Soochow Hopes Hematonosis Hospital	1
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	164
The First Affiliated Hospital of Soochow University	164
The First People's Hospital of Changzhou	35
Zhangjiagang First People's Hospital	4

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The First Affiliated Hospital of Soochow University	Suzhou	China	36